子宫颈内Foley球囊与B族链球菌定植患者标准化引产中临床绒毛膜羊膜炎的相关性
本研究为一项随机对照试验的二次分析,纳入491例原试验患者,其中467例已知B族链球菌状态并接受宫颈成熟。比较Foley球囊与仅米索前列醇对临床绒毛膜羊膜炎的影响,总体发生率为12.2%,两组无差异(12.6% vs 11.1%,P=.66),B族链球菌状态未修饰该关联(RR 0.93,95%CI 0.50-1.72)。结论认为Foley球囊在B族链球菌定植患者中可安全用于宫颈成熟。
要点
- Foley球囊组与仅米索前列醇组临床绒毛膜羊膜炎发生率无差异(12.6% vs 11.1%,P=.66)。
- B族链球菌状态未修饰Foley球囊与临床绒毛膜羊膜炎的关联(RR 0.93,95%CI 0.50-1.72)。
- 作者认为Foley球囊在B族链球菌定植患者中可安全用于宫颈成熟。
核心结论
- 在采用标准化产程方案的随机试验二次分析中,Foley球囊使用未增加总体及B族链球菌定植患者的感染性发病率,作者认为可安全用于B族链球菌定植者的宫颈成熟。
研究设计与样本
- 本研究为随机对照试验「机械与药物引产方法:一项随机对照试验」的二次分析,该试验在标准化产程方案内比较宫颈成熟剂。
- 纳入足月、单胎、胎膜完整、宫颈条件不佳(Bishop评分≤6分且扩张≤2 cm)且已知B族链球菌状态的患者。
- 原试验共纳入491例患者,其中467例已知B族链球菌状态并接受宫颈成熟,182例(39.0%)有B族链球菌定植,285例(61.0%)无定植;73.0%接受Foley球囊,27.0%未接受。
- 比较Foley球囊(单用、联合缩宫素或联合米索前列醇)与仅米索前列醇,主要结局为根据美国妇产科医师学会指南定义的临床绒毛膜羊膜炎。
主要发现
- 总体临床绒毛膜羊膜炎发生率为12.2%,Foley球囊组与无Foley球囊组无差异(12.6% vs 11.1%,P=.66)。
- B族链球菌状态未修饰Foley球囊使用与临床绒毛膜羊膜炎的关联(相对风险0.93,95%置信区间0.50-1.72)。
- 调整孕周后该关联不变(调整相对风险0.87,95%置信区间0.45-1.67)。
- 两组其他母儿结局相似。
关键数值与推荐
- 临床绒毛膜羊膜炎定义基于美国妇产科医师学会指南。
- 宫颈条件不佳定义为Bishop评分≤6分且扩张≤2 cm。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracervical Foley balloons are commonly used for cervical ripening, but there has been a historical concern regarding an increased risk of clinical chorioamnionitis with Foley balloon use in patients with group B streptococcus. OBJECTIVE: This study aimed to determine whether intracervical Foley balloon use in patients with group B streptococcus is associated with an increased risk of clinical chorioamnionitis. STUDY DESIGN: This was a secondary analysis of a randomized controlled trial Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial that compared cervical ripening agents within a standardized labor protocol. Foley balloon (alone, with oxytocin, or with misoprostol) was compared with misoprostol only to evaluate the primary outcome of clinical chorioamnionitis, defined based on the American College of Obstetricians and Gynecologists guidelines. Patients with a term, singleton pregnancy with intact membranes and an unfavorable cervix (Bishop score of ≤6 and dilation ≤2 cm) and a known group B streptococcus status were included. The secondary outcomes included a composite postpartum maternal infectious outcome consisting of any occurrence of endometritis, wound infection, postpartum urinary tract infection, or maternal sepsis; additional secondary outcomes included neonatal outcomes. Binomial regression with robust error variance was used to evaluate whether group B streptococcus status modified the relationship between Foley balloon use and clinical chorioamnionitis and to adjust for confounders. RESULTS: A total of 491 patients were enrolled in the original trial. Of these patients, 467 had a known group B streptococcus status and underwent cervical ripening: 182 (39.0%) had group B streptococcus, and 285 (61.0%) did not have group B streptococcus. Moreover, 73.0% of patients received a Foley balloon, and 27.0% of patients did not receive a Foley balloon. There was no difference in the demographic or clinical characteristics between groups. The overall rate of clinical chorioamnionitis was 12.2%, with no difference between those with and without a Foley balloon (12.6% vs 11.1%, respectively; P=.66). Group B streptococcus status did not modify the association between Foley balloon use and clinical chorioamnionitis (relative risk, 0.93; 95% confidence interval, 0.50-1.72). This remained unchanged after adjusting for gestational age (adjusted relative risk, 0.87; 95% confidence interval, 0.45-1.67). Furthermore, other maternal and neonatal outcomes were similar between groups. CONCLUSION: In this secondary analysis of a large randomized trial using a standardized labor protocol, there was no increased risk of infectious morbidity with Foley balloon use in patients overall and in patients with group B streptococcus. Our findings support that a Foley balloon can be safely used for cervical ripening in patients with group B streptococcus colonization.
引用
- Bromwich KA, McCoy JA, Cahill AG, et al. Association between intracervical Foley balloon and clinical chorioamnionitis among patients with group B streptococcus colonization undergoing induction with standardized labor management. Am J Obstet Gynecol MFM. 2023. PMID: 37741625. doi:10.1016/j.ajogmf.2023.101167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。